SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
  
 
C07D HETEROCYCLIC COMPOUNDS 5157
 
  
 
C07K PEPTIDES 2134
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205
 
  
 
B82Y SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE  OR TREATMENT OF NANO-STRUCTURES152

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0246,236 METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF COMPOUNDSDec 12, 16Aug 31, 17[A61K, B82Y]
2017/0240,562 PYRIDINE COMPOUNDSJul 07, 16Aug 24, 17[C07D]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920068 Pyridine compoundsJul 07, 16Mar 20, 18[A61K, C07D]
9180161 CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disordersFeb 28, 11Nov 10, 15[A61K, C07K]
8506965 R-RAS activity in vascular regulationNov 11, 05Aug 13, 13[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0311,795 PYRIMIDINE DIAMINE DERIVATIVES AS INHIBITORS OF CYTOSOLIC HSP90AbandonedJul 02, 15Oct 27, 16[A61K, C07D]
2016/0046,616 NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPYAbandonedMar 17, 14Feb 18, 16[C07D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.